Document:

Exhibit 4.4

   

  WARRANT AGREEMENT

   

  between

   

  HEARTLAND MEDIA ACQUISITION CORP.

   

  and

   

  CONTINENTAL STOCK TRANSFER & TRUST COMPANY

   

  THIS WARRANT AGREEMENT (this “Agreement”), dated as of [●], 2022,
      is by and between Heartland Media Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”).

   

  WHEREAS, the Company is engaged in an initial public offering (the “Offering”)
      of units of the Company’s equity securities, each such unit comprised of one share of Common Stock (as defined below) and one-half of one Public Warrant (as defined below) (the “Units”) and, in connection therewith, has determined to issue and
      deliver 8,750,000 redeemable warrants (or up to 10,062,500 redeemable warrants to the extent the Over-allotment Option (as defined below) is exercised) to investors in the Offering (the “Public Warrants”); and

   

  WHEREAS, the Company has entered into that certain Private Placement
      Warrants Purchase Agreement with Heartland Sponsor LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor has agreed to purchase an aggregate of 9,875,000 warrants (or 11,056,250 warrants if the Over-allotment
      Option is exercised in full) (the “Private Placement Warrants”) simultaneously with the closing of the Offering (and the closing of the Over-allotment Option, if applicable) at a purchase price of $1.00 per Private Placement Warrant, with each
      Private Placement Warrant bearing the legend set forth in Exhibit B hereto; and

   

  WHEREAS, in order to fund the Company’s working capital deficiencies or
      finance transaction costs in connection with an intended initial Business Combination (as defined below), the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company
      funds as the Company may require, of which up to $1,500,000 of such loans may be convertible into up to an additional 1,500,000 Private Placement Warrants at a price of $1.00 per warrant (the “Working Capital Warrants” and, collectively with
      the Public Warrants and the Private Placement Warrants, the “Warrants”); and

   

  WHEREAS, each whole Warrant entitles the holder thereof to purchase one
      share of Class A common stock of the Company, par value $0.0001 per share (“Common Stock”), for $11.50 per whole share, subject to adjustment as described herein. Only whole Warrants are exercisable. A holder of the Warrants will not be able
      to exercise any fraction of a Warrant; and

   

  WHEREAS, the Company has filed with the Securities and Exchange
      Commission (the “Commission”) a registration statement on Form S-1, File No. 333-261374, as amended (the “Registration Statement”), and prospectus, as amended (the “Prospectus”), for the registration, under the Securities Act of
      1933, as amended (the “Securities Act”), of the Units, the Public Warrants and the shares of Common Stock included in the Units (such shares, the “Offering Shares”); and

   

  

  
     

    
      
 

  

   

  WHEREAS, the Company desires the Warrant Agent to act on behalf of the
      Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants; and

   

  WHEREAS, the Company desires to provide for the form and provisions of
      the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent and the holders of the Warrants; and

   

  WHEREAS, all acts and things have been done and performed which are
      necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent (if a physical certificate is issued), as provided herein, the valid, binding and legal obligations of the Company, and to
      authorize the execution and delivery of this Agreement.

   

  NOW, THEREFORE, in consideration of the mutual agreements herein
      contained, the parties hereto agree as follows:

   

  1.            Appointment of Warrant Agent. The Company hereby
      appoints Continental Stock Transfer & Trust Company to act as agent for the Company for the Warrants, and Continental Stock Transfer & Trust Company hereby accepts such appointment and agrees to perform the same in accordance with the terms
      and conditions set forth in this Agreement.

   

  2.            Warrants.

   

  2.1          Form of Warrant. Each Warrant shall initially be
      issued in registered form only.

   

  2.2          Effect of Countersignature. If a physical certificate
      is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant certificate shall be invalid and of no effect and may not be exercised by the holder thereof.

   

  2.3          Registration.

   

  2.3.1        Warrant Register. The Warrant Agent shall maintain
      books (the “Warrant Register”) for the registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the
      respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company. All of the Public Warrants shall initially be issued in book-entry form through the facilities of The
      Depository Trust Company (the “Depositary”) and registered in the name of Cede & Co., a nominee of the Depositary. Ownership of beneficial interests in the Public Warrants shall be shown on, and the transfer of such ownership shall be
      effected through, records maintained by institutions that have accounts with the Depositary (each such institution, with respect to a Warrant in its account, a “Participant”).

   

  If the Depositary subsequently ceases to make its book-entry settlement
      system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other arrangements for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the
      Public Warrants available in, book-entry form, the Warrant Agent shall deliver to the Depositary (i) written instructions to deliver to the Warrant Agent for cancellation each book-entry Public Warrant and (ii) definitive certificates in physical
      form evidencing such Warrants (“Definitive Warrant Certificates”), which shall be in the form annexed hereto as Exhibit A.

   

  

  
    2

    
      
 

  

   

  Physical certificates, if issued, shall be signed by, or bear the facsimile
      signature of, the Chairman of the Company’s board of directors (the “Board”) or the Chief Executive Officer, Chief Financial Officer, Secretary or other principal officer of the Company. In the event the person whose facsimile signature has
      been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance.

   

  2.3.2        Registered Holder. Prior to due presentment for
      registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute owner of such Warrant and of
      each Warrant represented thereby (notwithstanding any notation of ownership or other writing on any physical certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes,
      and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

   

  2.4          Detachability of Warrants. The shares of Common Stock
      and Public Warrants comprising the Units shall begin separate trading on the 52nd day following the date of the Prospectus or, if such 52nd day is not a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City are
      generally open for normal business (a “Business Day”), then on the immediately succeeding Business Day following such date, or earlier with the consent of BofA Securities, Inc. and Moelis & Company LLC, as representatives of the several
      underwriters participating in the Offering (the “Detachment Date”), but in no event shall the shares of Common Stock and the Public Warrants comprising the Units be separately traded until (A) the Company has filed a Current Report on Form 8-K
      with the Commission containing an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Offering, including the proceeds then received by the Company from the exercise by the underwriters participating in the
      Offering of their right to purchase additional Units in the Offering (the “Over-allotment Option”), if the Over-allotment Option is exercised prior to the filing of the Current Report on Form 8-K (and, if the Over-allotment Option is exercised
      following the initial filing of such Current Report on Form 8-K, a second or amended Current Report on Form 8-K will be filed to provide updated financial information to reflect the exercise of the Over-allotment Option), and (B) the Company issues a
      press release and files with the Commission a Current Report on Form 8-K announcing when such separate trading shall begin.

   

  2.5          No Fractional Warrants Other Than as Part of Units.
      The Company shall not issue fractional Warrants other than as part of the Units. If, upon the detachment of Public Warrants from Units or otherwise, a holder of Warrants would be entitled to receive a fractional Warrant, the Company shall round down
      to the nearest whole number the number of Warrants to be issued to such holder.

   

  2.6          Private Placement Warrants and Working Capital Warrants.
      The Private Placement Warrants and the Working Capital Warrants shall be identical to the Public Warrants, except that so long as they are held by the original holders thereof or any of their Permitted Transferees (as defined below), as applicable,
      the Private Placement Warrants and Working Capital Warrants: (i) may be exercised for cash or on a cashless basis, pursuant to subsection 3.3.1(c) hereof, (ii) including the shares of Common Stock issuable upon exercise of such Private
      Placement Warrants and Working Capital Warrants, may not be transferred, assigned or sold until thirty (30) days after the completion by the Company of an initial Business Combination, and (iii) shall not be redeemable by the Company pursuant to Section
        6.1 hereof; provided, however, that in the case of clause (ii), the Private Placement Warrants, Working Capital Warrants and any shares of Common Stock issued upon exercise of the Private Placement Warrants or Working Capital Warrants that, in
      each case are held by the original holders thereof or any of their Permitted Transferees may be transferred by the holders thereof prior to that thirtieth day:

   

  

   

  (a)            to the Company’s officers or directors, any affiliates or
      family members of any of the Company’s officers or directors, any members of the Sponsor or any affiliates of the Sponsor;

   

  (b)            in the case of an individual, by gift to a member of the
      individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such individual, or to a charitable organization;

   

  (c)            in the case of an individual, by virtue of laws of descent
      and distribution upon death of the individual;

   

  
    3

    
      
 

  

   

    

  (d)            in the case of an individual, pursuant to a qualified
      domestic relations order;

   

  (e)            by private sales or transfers made in connection with the
      consummation of a business combination at prices no greater than the price at which the applicable Warrants or the shares of Common Stock, as the case may be, were originally purchased;

   

  (f)             in the event of the Company’s liquidation prior to the
      completion of its initial Business Combination;

   

  (g)            by virtue of the laws of the State of Delaware or the
      Sponsor’s limited liability company agreement, as amended, upon dissolution of the Sponsor; or

   

  (h)            in the event of the Company’s completion of a liquidation,
      merger, stock exchange, reorganization or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property subsequent to the completion of
      the Company’s initial Business Combination;

   

  provided, however, that in the case of clauses (a) through
      (g), these permitted transferees (the “Permitted Transferees”) must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement (described in the Prospectus)
      between the Company and its initial stockholders.

   

  2.7          Working Capital Warrants. Each of the Working Capital
      Warrants shall be identical to the Private Placement Warrants. Except as expressly provided herein or the context otherwise requires, the Working Capital Warrants shall be treated as Private Placement Warrants under this Agreement.

   

  3.            Terms and Exercise of Warrants.

   

  3.1          Warrant Price. Each whole Warrant shall, when
      countersigned by the Warrant Agent (if a physical certificate is issued), entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number of shares of Common Stock stated
      therein, at the price of $11.50 per share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Agreement shall mean the price per share
      (including in cash or by payment of Warrants pursuant to a “cashless exercise,” to the extent permitted hereunder) described in the prior sentence at which shares of Common Stock may be purchased at the time a Warrant is exercised. The Company, in
      its sole discretion, may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days, provided, that the Company shall provide at least twenty (20) days prior
      written notice of such reduction to Registered Holders of the Warrants and, provided further that any such reduction shall be identical among all of the Warrants.

   

  

  
    4

    
      
 

  

   

  3.2          Duration of Warrants. A Warrant may be exercised only
      during the period (the “Exercise Period”) commencing on the later of: (i) the date that is thirty (30) days after the first date on which the Company completes a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
      or similar business combination, involving the Company and one or more businesses (a “Business Combination”) and (ii) the date that is twelve (12) months from the date of the closing of the Offering, and terminating at the earliest to occur
      of: (x) 5:00 p.m., New York City time, on the date that is five (5) years after the date on which the Company completes its initial Business Combination, (y) the liquidation of the Company, if the Company fails to complete a Business Combination and
      (z) the Redemption Date (as defined below) for such Warrant as provided in Section 6.3 hereof (the “Expiration Date”); provided, however, that the exercise of any Warrant shall be subject to the satisfaction of any
      applicable conditions, as set forth in subsection 3.3.2 below with respect to an effective registration statement or a valid exemption therefrom being available. Except with respect to the right to receive the Redemption Price (as defined
      below) (other than with respect to a Private Placement Warrant or a Working Capital Warrant held by the original holders thereof or any of their Permitted Transferees in connection with a redemption pursuant to Section 6.1 hereof) in the
      event of a redemption (as set forth in Section 6 hereof), each Warrant (other than a Private Placement Warrant or a Working Capital Warrant held by the original holders thereof or their Permitted Transferees, in the event of a redemption
      pursuant to Section 6.1 hereof) not exercised on or before the Expiration Date shall become null and void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m., New York City time, on the
      Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided that the Company shall provide at least twenty (20) days prior written notice of any such extension to
      Registered Holders of the Warrants and, provided further that any such extension shall be identical in duration among all the Warrants.

   

  3.3          Exercise of Warrants.

   

  3.3.1        Payment. Subject to the provisions of the Warrant and
      this Agreement, a Warrant may be exercised by the Registered Holder thereof by delivering to the Warrant Agent at its Compliance Department (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised, or, in the case of a Warrant
      represented by a book-entry, the Warrants to be exercised (the “Book-Entry Warrants”) on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes in writing by the Warrant Agent to the
      Depositary from time to time, (ii) an election to purchase (“Election to Purchase”) any shares of Common Stock pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of the Definitive
      Warrant Certificate or, in the case of a Book-Entry Warrant, properly delivered by the Participant in accordance with the Depositary’s procedures, and (iii) payment in full of the Warrant Price for each full share of Common Stock as to which the
      Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the shares of Common Stock and the issuance of such shares of Common Stock, as follows:

   

  (a)           in lawful money of the United States, in good certified
      check or wire payable to the order of the Warrant Agent;

   

  (b)           in the event of a redemption pursuant to Section 6.1
      hereof in which the Board has elected to require all holders of the Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants to be exercised by a holder for that number of shares of Common Stock equal to the lesser of
      (A) the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market Value,” as defined in this subsection 3.3.1(b), over the Warrant Price by (y)
      the Fair Market Value and (B) the product of 0.361 and the number of Warrants surrendered by such holder. Solely for purposes of this subsection 3.3.1(b), the “Fair Market Value” shall mean the volume-weighted average price of the shares of
      Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the Warrants, pursuant to Section 6 hereof;

   

  

  
    5

    
      
 

  

   

  (c)           with respect to any Private Placement Warrant or Working
      Capital Warrant, so long as such Private Placement Warrant or Working Capital Warrant is held by the original holders thereof or their Permitted Transferees, by surrendering the Warrants to be exercised by a holder for that number of shares of Common
      Stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market Value,” as defined in this subsection 3.3.1(c),
      over the Warrant Price by (y) the Fair Market Value and (B) the product of 0.361 and the number of Warrants surrendered by such holder. Solely for purposes of this subsection 3.3.1(c), the “Fair Market Value” shall mean the volume-weighted
      average price of the shares of Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which notice of exercise of the Private Placement Warrant or Working Capital Warrant, as the case may be, is sent to the
      Warrant Agent;

   

  (d)           as provided in Section 6.2 with respect to a
      Make-Whole Exercise; or

   

  (e)           as provided in Section 7.4 hereof.

   

  3.3.2        Issuance of Shares of Common Stock on Exercise. As
      soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder of such Warrant a
      book-entry position or certificate, as applicable, for the number of full shares of Common Stock to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been
      exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares of Common Stock as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated
      to deliver any shares of Common Stock pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock
      issuable upon exercise of the Warrants is then effective and a current prospectus relating to those shares of Common Stock is available, subject to the Company’s satisfying its obligations under Section 7.4, or such Warrant may be exercised
      on a “cashless basis” in accordance with the terms of this Agreement. No Warrant shall be exercisable and the Company shall not be obligated to issue any shares to holders seeking to exercise their Warrants, unless the issuance of the shares upon
      such exercise is registered or qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants. In no event will the Company be required to net cash
      settle the Warrant exercise. The Company may require holders of Public Warrants to settle their Public Warrants on a “cashless basis” pursuant to Section 7.4. If, by reason of any exercise of Warrants on a “cashless basis,” the holder of any
      Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share of Common Stock, the Company shall round down to the nearest whole number, the number of shares of Common Stock to be issued to such holder.

   

  3.3.3        Valid Issuance. All shares of Common Stock issued upon
      the proper exercise of a Warrant in conformity with this Agreement shall be validly issued, fully paid and non-assessable.

   

  3.3.4        Date of Issuance. Each person in whose name any
      book-entry position or certificate, as applicable, for shares of Common Stock is issued shall for all purposes be deemed to have become the holder of record of such shares of Common Stock on the date on which the Warrant, or book-entry position
      representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date
      when the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to have become the holder of such shares of Common Stock at the close of business on the next succeeding date on which the
      share transfer books or book-entry system are open.

   

  

  
    6

    
      
 

  

   

  3.3.5        Maximum Percentage. A holder of a Warrant may notify
      the Company in writing in the event it elects to be subject to the provisions contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes such
      election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such
      holder (together with such holder’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as such holder may specify) (the “Maximum Percentage”) of the shares of Common
      Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such holder and its affiliates shall include the number of shares of
      Common Stock issuable upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock that would be issuable upon (x) exercise of the remaining, unexercised portion of the
      Warrant beneficially owned by such holder and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such holder and its affiliates (including, without
      limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this
      paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding shares of
      Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the
      Commission, as the case may be, (B) a more recent public announcement by the Company or (C) any other notice by the Company or the Company’s transfer agent setting forth the number of shares of Common Stock outstanding. For any reason at any time,
      upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing to such holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares
      of Common Stock shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By
      written notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however, that any such
      increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

   

  4.            Adjustments.

   

  4.1          Stock Dividends.

   

  4.1.1        Split-Ups. If after the date hereof, and subject to
      the provisions of Section 4.6 below, the number of outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common Stock, or by a split-up of shares of Common Stock or other similar event, then, on the
      effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock. A rights offering
      to holders of the Common Stock entitling holders to purchase shares of Common Stock at a price less than the “Fair Market Value” (as defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the
      number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for the Common Stock) multiplied by (ii) one (1) minus the
      quotient of (x) the price per share of Common Stock paid in such rights offering divided by (y) the Fair Market Value. For purposes of this subsection 4.1.1, (i) if the rights offering is for securities convertible into or exercisable for
      Common Stock, in determining the price payable for Common Stock, there shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “Fair Market Value” means the
      volume-weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market,
      regular way, without the right to receive such rights.

   

  

  
    7

    
      
 

  

   

  4.1.2        Extraordinary Dividends. If the Company, at any time
      while the Warrants are outstanding and unexpired, shall pay a dividend or make a distribution in cash, securities or other assets to the holders of the Common Stock on account of such shares of Common Stock (or other shares of the Company’s capital
      stock into which the Warrants are convertible), other than (A) as described in subsection 4.1.1 above, (B) Ordinary Cash Dividends (as defined below), (C) to satisfy the redemption rights of the holders of the Common Stock in connection with
      a proposed initial Business Combination, (D) to satisfy the redemption rights of the holders of Common Stock in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or
      timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Offering Shares if the Company does not complete the Business Combination within 18 months from the closing
      of the Offering or any extended time that the Company has to consummate a Business Combination beyond 18 months as a result of either (i) the election of the Company to extend such time up to an additional three months, subject to certain conditions,
      including the deposit of $1,750,000 (or $0.10 per unit) into the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the Company and Continental Stock Transfer & Trust
      Company, as trustee thereunder) or (ii) a stockholder vote to amend the Company’s amended and restated certificate of incorporation, or with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity,
      or (E) in connection with the redemption of all of the Offering Shares upon the failure of the Company to complete its initial Business Combination and any subsequent distribution of its assets upon its liquidation (any such non-excluded event being
      referred to herein as an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as determined by
      the Board, in good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Dividend. For purposes of this subsection 4.1.2, “Ordinary Cash Dividends” means any cash dividend or cash
      distribution which, when combined on a per share basis, with the per share amounts of all other cash dividends and cash distributions paid on the Common Stock during the 365-day period ending on the date of declaration of such dividend or
      distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of
      shares of Common Stock issuable on exercise of each Warrant) to the extent it does not exceed $0.50 per share.

   

  4.2          Aggregation of Shares. If after the date hereof, and
      subject to the provisions of Section 4.6 hereof, the number of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other similar event, then, on
      the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding
      shares of Common Stock.

   

  

  
    8

    
      
 

  

   

  4.3          Adjustments in Exercise Price.

   

  4.3.1        Whenever the number of shares of Common Stock purchasable upon
      the exercise of the Warrants is adjusted, as provided in subsection 4.1.1 or Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a
      fraction (x) the numerator of which shall be the number of shares of Common Stock purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so
      purchasable immediately thereafter.

   

  4.3.2        If (i) the Company issues additional shares of Common Stock or
      securities convertible into or exercisable or exchangeable for shares of Common Stock for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per
      share of Common Stock, with such issue price or effective issue price to be determined in good faith by the Board (and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any shares of Class B common stock
      of the Company, par value $0.0001 per share (the “Class B Common Stock”), held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “New Issuance Price”), (ii) aggregate gross proceeds from such issuances
      represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions) and (iii) the
      volume-weighted average trading price of the Common Stock during the 20-trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below
      $9.20 per share, then the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the New Issuance Price, and the $10.00 and $18.00 per share redemption trigger prices described in Section
        6.2 and Section 6.1, respectively, will be adjusted (to the nearest cent) to 100% and 180%, respectively, of the higher of the Market Value and the New Issuance Price.

   

  

  
    9

    
      
 

  

   

  4.4          Replacement of Securities upon Reorganization, etc.
      In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than a change under Section 4.1 or 4.2 hereof or that solely affects the par value of such shares of Common Stock), or in the case of
      any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding
      shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the
      holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable
      and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a
      dissolution following any such sale or transfer, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance” ); provided, however,
      that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other
      assets constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock in such consolidation or merger that
      affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock (other than a tender, exchange or redemption offer made by the Company in connection with
      redemption rights held by stockholders of the Company as provided for in the Company’s amended and restated certificate of incorporation or as a result of the redemption of shares of Common Stock by the Company if a proposed initial Business
      Combination is presented to the stockholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1)
      under the Exchange Act (or any successor rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act (or any successor rule)) and any members of any such
      group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of Common Stock, the holder of a Warrant shall be
      entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the expiration
      of such tender or exchange offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange
      offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; provided, further, that if less than 70% of the consideration receivable by the holders of Common Stock in the applicable event is
      payable in the form of common equity in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such
      event, and if the Registered Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 8-K filed with the Commission,
      the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than zero) minus (B)
      the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American
      Call on Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating such amount, (1) Section 6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be the volume-weighted average
      price of the shares of Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event, (3) the assumed volatility shall be the 90 day volatility obtained from the HVT
      function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining
      term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders of the shares of Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases, the
      volume-weighted average price of the shares of Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a
      change in shares of Common Stock covered by subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this Section 4.4. The provisions of this Section 4.4
      shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the Warrant.

   

  4.5          Notices of Changes in Warrant. Upon every adjustment
      of the Warrant Price or the number of shares of Common Stock issuable upon exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment and the
      increase or decrease, if any, in the number of shares of Common Stock purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the
      occurrence of any event specified in Sections 4.1, 4.2, 4.3 or 4.4, the Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address set forth for such holder in
      the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

   

  4.6          No Fractional Shares. Notwithstanding any provision
      contained in this Agreement to the contrary, the Company shall not issue fractional shares of Common Stock upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be
      entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to such holder.

   

  

  
    10

    
      
 

  

   

  4.7          Form of Warrant. The form of Warrant need not be
      changed because of any adjustment pursuant to this Section 4, and Warrants issued after such adjustment may state the same Warrant Price and the same number of shares of Common Stock as is stated in the Warrants initially issued pursuant to
      this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant
      thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

   

  4.8          Other Events. In case any event shall occur affecting
      the Company as to which none of the provisions of preceding subsections of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse impact on the Warrants and
      (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing, which shall
      give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such
      adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion.

   

  4.9          No Adjustment. For the avoidance of doubt, no
      adjustment shall be made to the terms of the Warrants solely as a result of an adjustment to the conversion ratio of the Class B Common Stock into Common Stock or the conversion of the Class B Common Stock into Common Stock, in each case, pursuant to
      the Company’s amended and restated certificate of incorporation, as amended from time to time.

   

  5.            Transfer and Exchange of Warrants.

   

  5.1          Registration of Transfer. The Warrant Agent shall
      register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, in the case of certificated Warrants, properly endorsed with signatures properly guaranteed and accompanied
      by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be
      delivered by the Warrant Agent to the Company from time to time upon request.

   

  5.2          Procedure for Surrender of Warrants. Warrants may be
      surrendered to the Warrant Agent, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so
      surrendered, representing an equal aggregate number of Warrants; provided, however, that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement Warrants and Working
      Capital Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the
      new Warrants must also bear a restrictive legend.

   

  5.3          Fractional Warrants. The Warrant Agent shall not be
      required to effect any registration of transfer or exchange of Warrants which would result in the issuance of a warrant certificate or book-entry position for a fraction of a warrant, except as part of the Units.

   

  

  
    11

    
      
 

  

   

  5.4          Service Charges. No service charge shall be made for
      any exchange or registration of transfer of Warrants.

   

  5.5          Warrant Execution and Countersignature. The Warrant
      Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the Warrant
      Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

   

  5.6          Transfer of Warrants. Prior to the Detachment Date,
      the Public Warrants may be transferred or exchanged only together with the Unit in which such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore, each transfer of a
      Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding the foregoing, the provisions of this Section 5.6 shall have no effect on any transfer of Warrants on and after the
      Detachment Date.

   

  6.            Redemption.

   

  6.1          Redemption of Warrants When the Price per Share of Common
        Stock Equals or Exceeds $18.00. Subject to Section 6.5 hereof, at any time while the Warrants are exercisable and prior to their expiration, the Company may, at its option, redeem all (and not part) of the outstanding Warrants, at the
      office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in Section 6.3 below, at the price (the “Redemption Price”) of $0.01 per Warrant, provided (i) that the last reported sale price
      of the Common Stock equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof), for any twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date
      on which notice of the redemption is given and (ii) that there is an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the
      30-day Redemption Period (as defined in Section 6.3 below) or the Company has elected to require the exercise of the Warrants on a “cashless basis” pursuant to subsection 3.3.1.

   

  6.2          Redemption of Warrants When the Price per Share of Common
        Stock Equals or Exceeds $10.00. Subject to Section 6.5 hereof, at any time while the Warrants are exercisable and prior to their expiration, the Company may, at its option, redeem all (and not part) of the outstanding Warrants, at the
      office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in Section 6.3 below, at a Redemption Price of $0.10 per Warrant, provided (i) that the last reported sale price of the Common Stock
      equals or exceeds $10.00 per share (subject to adjustment in compliance with Section 4 hereof), for any twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on which notice of
      the redemption is given, (ii) if the last reported sale price of the Common Stock is less than $18.00 (subject to adjustment in compliance with Section 4 hereof) for any twenty (20) trading days within the thirty (30) trading-day period
      ending on the third trading day prior to the date on which notice of the redemption is given, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants and (iii) there is an
      effective registration statement covering the Common Stock issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption Period. During the 30-day Redemption Period in connection with a
      redemption pursuant to this Section 6.2, Registered Holders of the Warrants may elect to exercise their Warrants on a “cashless basis” and receive a number of shares of Common Stock determined by reference to the table below, based on the
      Redemption Date (as defined below) (calculated for purposes of the table as the number of months that the corresponding Redemption Date precedes the expiration date of the Warrants) and the “Fair Market Value” (as such term is defined in this Section
        6.2) (a “Make-Whole Exercise”). Solely for purposes of this Section 6.2, “Fair Market Value” shall mean the volume-weighted average price of the Common Stock as reported during the ten (10) trading days immediately following the
      date on which notice of redemption pursuant to this Section 6.2 is sent to the Registered Holders. In connection with any redemption pursuant to this Section 6.2, the Company shall provide the Registered Holders with the Fair Market
      Value no later than one (1) Business Day after the ten (10) trading day period described above ends.

   

  

  
    12

    
      
 

  

   

  	 	 	Fair Market Value of Common Stock	 
	Redemption Date (period to
              expiration of warrants)	 	≤$10.00	 	 	$11.00	 	 	$12.00	 	 	$13.00	 	 	$14.00	 	 	$15.00	 	 	$16.00	 	 	$17.00	 	 	≥$18.00	 
	60 months	 	0.261	 	 	0.281	 	 	0.297	 	 	0.311	 	 	0.324	 	 	0.337	 	 	0.348	 	 	0.358	 	 	0.361	 
	57 months	 	0.257	 	 	0.277	 	 	0.294	 	 	0.310	 	 	0.324	 	 	0.337	 	 	0.348	 	 	0.358	 	 	0.361	 
	54 months	 	0.252	 	 	0.272	 	 	0.291	 	 	0.307	 	 	0.322	 	 	0.335	 	 	0.347	 	 	0.357	 	 	0.361	 
	51 months	 	0.246	 	 	0.268	 	 	0.287	 	 	0.304	 	 	0.320	 	 	0.333	 	 	0.346	 	 	0.357	 	 	0.361	 
	48 months	 	0.241	 	 	0.263	 	 	0.283	 	 	0.301	 	 	0.317	 	 	0.332	 	 	0.344	 	 	0.356	 	 	0.361	 
	45 months	 	0.235	 	 	0.258	 	 	0.279	 	 	0.298	 	 	0.315	 	 	0.330	 	 	0.343	 	 	0.356	 	 	0.361	 
	42 months	 	0.228	 	 	0.252	 	 	0.274	 	 	0.294	 	 	0.312	 	 	0.328	 	 	0.342	 	 	0.355	 	 	0.361	 
	39 months	 	0.221	 	 	0.246	 	 	0.269	 	 	0.290	 	 	0.309	 	 	0.325	 	 	0.340	 	 	0.354	 	 	0.361	 
	36 months	 	0.213	 	 	0.239	 	 	0.263	 	 	0.285	 	 	0.305	 	 	0.323	 	 	0.339	 	 	0.353	 	 	0.361	 
	33 months	 	0.205	 	 	0.232	 	 	0.257	 	 	0.280	 	 	0.301	 	 	0.320	 	 	0.337	 	 	0.352	 	 	0.361	 
	30 months	 	0.196	 	 	0.224	 	 	0.250	 	 	0.274	 	 	0.297	 	 	0.316	 	 	0.335	 	 	0.351	 	 	0.361	 
	27 months	 	0.185	 	 	0.214	 	 	0.242	 	 	0.268	 	 	0.291	 	 	0.313	 	 	0.332	 	 	0.350	 	 	0.361	 
	24 months	 	0.173	 	 	0.204	 	 	0.233	 	 	0.260	 	 	0.285	 	 	0.308	 	 	0.329	 	 	0.348	 	 	0.361	 
	21 months	 	0.161	 	 	0.193	 	 	0.223	 	 	0.252	 	 	0.279	 	 	0.304	 	 	0.326	 	 	0.347	 	 	0.361	 
	18 months	 	0.146	 	 	0.179	 	 	0.211	 	 	0.242	 	 	0.271	 	 	0.298	 	 	0.322	 	 	0.345	 	 	0.361	 
	15 months	 	0.130	 	 	0.164	 	 	0.197	 	 	0.230	 	 	0.262	 	 	0.291	 	 	0.317	 	 	0.342	 	 	0.361	 
	12 months	 	0.111	 	 	0.146	 	 	0.181	 	 	0.216	 	 	0.250	 	 	0.282	 	 	0.312	 	 	0.339	 	 	0.361	 
	9 months	 	0.090	 	 	0.125	 	 	0.162	 	 	0.199	 	 	0.237	 	 	0.272	 	 	0.305	 	 	0.336	 	 	0.361	 
	6 months	 	0.065	 	 	0.099	 	 	0.137	 	 	0.178	 	 	0.219	 	 	0.259	 	 	0.296	 	 	0.331	 	 	0.361	 
	3 months	 	0.034	 	 	0.065	 	 	0.104	 	 	0.150	 	 	0.197	 	 	0.243	 	 	0.286	 	 	0.326	 	 	0.361	 
	0 months	 	—	 	 	—	 	 	0.042	 	 	0.115	 	 	0.179	 	 	0.233	 	 	0.281	 	 	0.323	 	 	0.361	 

   

  The exact Fair Market Value and the Redemption Date may not be set forth in
      the table above, in which case, if the Fair Market Value is between two values in the table or the Redemption Date is between two redemption dates in the table, the number of shares of Common Stock to be issued for each Warrant exercised in a
      Make-Whole Exercise will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower Fair Market Values and the earlier and later redemption dates, as applicable, based on a 365 or 366-day year, as
      applicable.

   

  The stock prices set forth in the column headings of the table above shall
      be adjusted as of any date on which the number of shares of Common Stock issuable upon exercise of a Warrant is adjusted pursuant to Section 4.1 or Section 4.2. In such an event, the number of shares in the table above shall be
      adjusted by multiplying such share amounts by a fraction, the numerator of which is the number of shares deliverable upon exercise of a Warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon
      exercise of a Warrant as so adjusted. The number of shares in the table above shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a Warrant. If the Warrant Price is adjusted (i) pursuant to Section
        4.3.2, the adjusted share prices set forth in the column headings of the table above shall be multiplied by a fraction, the numerator of which is the higher of the Market Value and the New Issuance Price and the denominator of which is $10.00
      and (ii) in the case of an adjustment pursuant to Section 4.1.2, the adjusted share prices set forth in the column headings of the table above shall equal the unadjusted share price less the decrease in the Warrant Price of a Warrant pursuant
      to such exercise price adjustment. In no event will the number of shares issued in connection with a Make-Whole Exercise exceed 0.361 shares of Common Stock per Warrant (subject to adjustment).

   

  

  
    13

    
      
 

  

   

  6.3          Date Fixed for, and Notice of, Redemption. In the
      event that the Company elects to redeem all of the Warrants pursuant to Sections 6.1 or 6.2, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class mail,
      postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (the “30-day Redemption Period”) to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on the Warrant
      Register. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the Registered Holder received such notice.

   

  6.4          Exercise After Notice of Redemption. The Warrants may
      be exercised for cash (or on a “cashless basis” in accordance with subsection 3.3.1(b) or Section 6.2 of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.3
      hereof and prior to the Redemption Date. In the event that the Company determines to require all holders of Warrants to exercise their Warrants on a “cashless basis” pursuant to subsection 3.3.1(b), the notice of redemption shall contain the
      information necessary to calculate the number of shares of Common Stock to be received upon exercise of the Warrants, including the “Fair Market Value” (as such term is defined in subsection 3.3.1(b) hereof) in such case. On and after the
      Redemption Date, the record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption Price.

   

  6.5          Exclusion of Private Placement Warrants and Working
        Capital Warrants. The Company agrees that the redemption rights provided in Section 6.1 hereof shall not apply to the Private Placement Warrants or the Working Capital Warrants if at the time of the redemption such Private Placement
      Warrants or Working Capital Warrants continue to be held by the original holders thereof or their Permitted Transferees. However, once such Private Placement Warrants or Working Capital Warrants are transferred (other than to the original holders
      thereof or Permitted Transferees in accordance with Section 2.6), the Company may redeem such Private Placement Warrants or Working Capital Warrants pursuant to Section 6.1 hereof, provided that the criteria for redemption are met,
      including the opportunity of the holder of such Private Placement Warrants or Working Capital Warrants to exercise such Private Placement Warrants or Working Capital Warrants prior to redemption pursuant to Section 6.4. Private Placement
      Warrants and Working Capital Warrants that are transferred to persons other than the original holders thereof or Permitted Transferees shall upon such transfer cease to be Private Placement Warrants or Working Capital Warrants, respectively, and
      shall become Public Warrants under this Agreement.

   

  7.            Other Provisions Relating to Rights of Holders of Warrants.

   

  7.1          No Rights as Stockholder. A Warrant does not entitle
      the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as
      stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter.

   

  7.2          Lost, Stolen, Mutilated or Destroyed Warrants. If any
      Warrant is lost, stolen, mutilated or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),
      issue a new Warrant of like denomination, tenor and date as the Warrant so lost, stolen, mutilated or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen,
      mutilated or destroyed Warrant shall be at any time enforceable by anyone.

   

  

  
    14

    
      
 

  

   

  7.3          Reservation of Common Stock. The Company shall at all
      times reserve and keep available a number of its authorized but unissued shares of Common Stock that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

   

  7.4          Registration of Common Stock; Cashless Exercise at
        Company’s Option.

   

  7.4.1        Registration of the Common Stock. The Company agrees
      that as soon as practicable, but in no event later than twenty (20) Business Days after the closing of its initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission a registration statement under the
      Securities Act covering the issuance of the shares of Common Stock issuable upon exercise of the Warrants. The Company shall use its commercially reasonable efforts to cause the same to become effective within sixty (60) Business Days following the
      closing of its initial Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the redemption or expiration of the Warrants in accordance with the provisions of this
      Agreement. If any such registration statement has not been declared effective by the sixtieth (60th) Business Day following the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning on the
      sixty-first (61st) Business Day after the closing of the Business Combination and ending upon such registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have maintained an
      effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act (or any
      successor rule) or another exemption) for that number of shares of Common Stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of
      the “Fair Market Value” (as defined below) over the Warrant Price by (y) the Fair Market Value and (B) the product of 0.361 and the number of Warrants surrendered for exchange. Solely for purposes of this subsection 7.4.1, “Fair Market Value”
      shall mean the volume-weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the third trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such
      Warrants or its securities broker or intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of a Public Warrant, the
      Company shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with
      this subsection 7.4.1 is not required to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely tradable under United States federal securities laws by anyone who is not an
      affiliate (as such term is defined in Rule 144 under the Securities Act (or any successor rule)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in subsection 7.4.2, for the avoidance of
      any doubt, unless and until all of the Warrants have been exercised or redeemed, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this subsection 7.4.1.

   

  7.4.2        Cashless Exercise at Company’s Option. If the Common
      Stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act (or any successor rule), the Company may,
      at its option, (i) require holders of Public Warrants who exercise Public Warrants to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) as described in subsection
        7.4.1 and (ii) in the event the Company so elects, the Company shall (x) not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the Common Stock issuable upon exercise of the
      Warrants, notwithstanding anything in this Agreement to the contrary, and (y) use its commercially reasonable efforts to register or qualify the Common Stock issuable upon exercise of the Public Warrants under the blue sky laws of the state of
      residence of the exercising Public Warrant holder to the extent an exemption is not available.

   

  

  
    15

    
      
 

  

   

  8.            Concerning the Warrant Agent and Other Matters.

   

  8.1          Payment of Taxes. The Company shall from time to time
      promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of the Warrants, but the Company shall not be obligated to pay any
      transfer taxes in respect of the Warrants or such shares of Common Stock.

   

  8.2          Resignation, Consolidation or Merger of Warrant Agent.

   

  8.2.1        Appointment of Successor Warrant Agent. The Warrant
      Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes
      vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has
      been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the Company), then the holder of any Warrant may apply to the
      Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized
      and existing under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and subject to
      supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties and obligations of its predecessor Warrant Agent with like effect as
      if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
      transferring to such successor Warrant Agent all the authority, powers and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge and deliver any and all
      instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties and obligations.

   

  8.2.2        Notice of Successor Warrant Agent. In the event a
      successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent and the Company’s transfer agent for the Common Stock not later than the effective date of any such appointment.

   

  8.2.3        Merger or Consolidation of Warrant Agent. Any
      corporation into which the Warrant Agent may be merged or with which it may be consolidated or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this
      Agreement without any further act.

   

  8.3          Fees and Expenses of Warrant Agent.

   

  8.3.1        Remuneration. The Company agrees to pay the Warrant
      Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in
      the execution of its duties hereunder.

   

  

  
    16

    
      
 

  

   

  8.3.2        Further Assurances. The Company agrees to perform,
      execute, acknowledge and deliver or cause to be performed, executed, acknowledged and delivered all such further and other acts, instruments and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the
      provisions of this Agreement.

   

  8.4          Liability of Warrant Agent.

   

  8.4.1        Reliance on Company Statement. Whenever in the
      performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless
      other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer, Secretary or Chairman of the Board of the
      Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

   

  8.4.2        Indemnity. The Warrant Agent shall be liable hereunder
      only for its own gross negligence, willful misconduct or bad faith. The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees, for anything done or
      omitted by the Warrant Agent in the execution of this Agreement, except as a result of the Warrant Agent’s gross negligence, willful misconduct or bad faith.

   

  8.4.3        Exclusions. The Warrant Agent shall have no
      responsibility with respect to the validity of this Agreement or with respect to the validity or execution of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any covenant
      or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method or amount of any such
      adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock
      to be issued pursuant to this Agreement or any Warrant or as to whether any shares of Common Stock shall, when issued, be valid and fully paid and non-assessable.

   

  8.5          Acceptance of Agency. The Warrant Agent hereby
      accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account
      for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise of the Warrants.

   

  8.6          Waiver. The Warrant Agent has no right of set-off or
      any other right, title, interest or claim of any kind (“Claim”) in, or to any distribution of, the Trust Account and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any
      reason whatsoever. The Warrant Agent hereby waives any and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

   

  9.            Miscellaneous Provisions.

   

  9.1          Successors. All the covenants and provisions of this
      Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns.

   

  

  
    17

    
      
 

  

   

  9.2          Notices. Any notice, statement or demand authorized
      by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service
      within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows:

   

  Heartland Media Acquisition Corp.

      3282 Northside Pkwy Suite 275

      Atlanta, Georgia 30327

      Attention: Robert S. Prather, Jr.

   

  Any notice, statement or demand authorized by this Agreement to be given or
      made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit
      of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

   

  Continental Stock Transfer & Trust Company

      1 State Street, 30th Floor

      New York, New York 10004

      Attention: Compliance Department

   

  With a copy in each case to:

   

  Proskauer Rose LLP

      Eleven Times Square

      New York, New York 10036

      Attn: Daniel Forman, Louis Rambo

   

  and

   

  Davis Polk & Wardwell LLP

      450 Lexington Avenue

      New York, New York 10017

      Attn: Derek Dostal, Deanna Kirkpatrick

   

  and

   

  BofA Securities, Inc.

      One Bryant Park

      New York, New York 10036

      Attn: ECM Legal

   

  and

   

  Moelis & Company LLC

      399 Park Avenue, 5th Floor

      New York, New York 10022

      Attn: Steven Halperin

      Email: steven.halperin@moelis.com

   

  

  
    18

    
      
 

  

   

  9.3          Applicable Law. The validity, interpretation, and
      performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another
      jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement, including under the Securities Act, shall be brought and enforced in the courts of the State of New York
      or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such
      courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this Section 9.3 will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal
      district courts of the United States of America have exclusive jurisdiction. Any person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section
        9.3. If any action, the subject matter of which is within the scope of the forum provisions above, is filed in a court other than a court located within the State of New York or the United States District Court for the Southern District of New
      York (a “foreign action”) in the name of any Warrant holder, such Warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located within the State of New York in connection with
      any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such Warrant holder in any such enforcement action by service upon such Warrant holder’s counsel
      in the foreign action as agent for such Warrant holder.

   

  9.4          Persons Having Rights under this Agreement. Nothing
      in this Agreement shall be construed to confer upon, or give to, any person or corporation other than the parties hereto and the Registered Holders of the Warrants any right, remedy or claim under or by reason of this Agreement or of any covenant,
      condition, stipulation, promise or agreement hereof. All covenants, conditions, stipulations, promises and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and
      of the Registered Holders of the Warrants.

   

  9.5          Examination of the Warrant Agreement. A copy of this
      Agreement shall be available at all reasonable times at the office of the Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to
      submit his Warrant for inspection by it.

   

  9.6          Counterparts. This Agreement may be executed in
      counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same instrument. The words “execution,” “signed,” “signature” and words of like import in this Agreement
      or in any other certificate, agreement or document related to this Agreement shall include images of manually executed signatures transmitted by facsimile or other electronic format (including, without limitation, “pdf,” “tif” or “jpg”) and other
      electronic signatures (including, without limitation, DocuSign and AdobeSign). The use of electronic signatures and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received or
      stored by electronic means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal
      Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the
      Uniform Commercial Code.

   

  9.7          Effect of Headings. The section headings herein are
      for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.

   

  

  
    19

    
      
 

  

   

  9.8          Amendments. This Agreement may be amended by the
      parties hereto without the consent of any Registered Holder for the purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with respect to matters or
      questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the Registered Holders. All other modifications or amendments, including any modification or
      amendment to increase the Warrant Price or shorten the Exercise Period and any amendment to the terms of only the Private Placement Warrants and/or Working Capital Warrants, shall require the vote or written consent of the Registered Holders of 65%
      of the then outstanding Public Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the
      Registered Holders.

   

  9.9          Severability. This Agreement shall be deemed
      severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
      term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

   

   

    

  [Signature Page Follows]

   

  
    20

    
      
 

  

   

  IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
      duly executed as of the date first above written.

   

  

  	 	HEARTLAND MEDIA ACQUISITION CORP.
	 	 	 
	 	By:	 
	 	Name: Robert S. Prather, Jr.
	 	Title:   Chief Executive Officer
	 	 	 
	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	 	 	 
	 	By:	 
	 	Name:
	 	Title:

   

   

    

  [Signature Page to Warrant Agreement] 

    

   

    

  
     

    
      
 

  

   

  Exhibit A

   

  Form of Warrant Certificate

   

  [FACE]

   

  Number

   

  Warrants

   

  THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO

      THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

      IN THE WARRANT AGREEMENT DESCRIBED BELOW

   

  HEARTLAND MEDIA ACQUISITION CORP.

      Incorporated Under the Laws of the State of Delaware

   

  CUSIP [●]

   

  Warrant Certificate

   

  This Warrant Certificate certifies that               , or
      registered assigns, is the registered holder of warrant(s) evidenced hereby (the “Warrants” and each, a “Warrant”) to purchase shares of Class A common stock, $0.0001 par value per share (“Common Stock”), of Heartland Media
      Acquisition Corp., a Delaware corporation (the “Company”). Each Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to below, to receive from the Company that number of fully paid and
      non-assessable shares of Common Stock as set forth below, at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement, payable in lawful money (or through “cashless exercise” as provided for in the
      Warrant Agreement) of the United States of America upon surrender of this Warrant Certificate and payment of the Exercise Price at the office or agency of the Warrant Agent referred to below, subject to the conditions set forth herein and in the
      Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

   

  Each whole Warrant is initially exercisable for one fully paid and
      non-assessable share of Common Stock. The number of shares of Common Stock issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement.

   

  The initial Exercise Price per share of Common Stock for any Warrant is
      equal to $11.50 per share. If, upon the exercise of Warrants, a holder would be entitled to receive a fractional interest in a share of Common Stock, the Company will, upon exercise, round down to the nearest whole number the number of shares of
      Common Stock to be issued to the Warrant holder. The Exercise Price is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement.

   

  Subject to the conditions set forth in the Warrant Agreement, the
      Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period, such Warrants shall become null and void. The Warrants may be redeemed, subject to certain conditions, as set forth in the
      Warrant Agreement.

   

  

  
    A-1 

    
      
 

  

   

  Reference is hereby made to the further provisions of this Warrant
      Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as though fully set forth at this place.

   

  This Warrant Certificate shall not be valid unless countersigned by the
      Warrant Agent, as such term is used in the Warrant Agreement.

   

  This Warrant Certificate shall be governed by and construed in accordance
      with the internal laws of the State of New York, without regard to conflicts of laws principles thereof.

   

  	 	HEARTLAND MEDIA ACQUISITION CORP.
	 	 	 
	 	By:	 
	 	Name: 
	 	Title:   
	 	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	 	 	 
	 	By:	 
	 	Name:
	 	Title:

   

  
    A-2

    
      
 

  

   

  Form of Warrant Certificate

   

  [REVERSE]

   

  The Warrants evidenced by this Warrant Certificate are part of a duly
      authorized issue of Warrants entitling the holder on exercise to receive shares of Common Stock and are issued or to be issued pursuant to a Warrant Agreement dated as of [●], 2022 (the “Warrant Agreement”), duly executed and delivered by the
      Company to Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated by reference in and made a part of this instrument and is hereby referred
      to for a description of the rights, limitation of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder” meaning the Registered Holders or Registered
      Holder) of the Warrants. A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the
      Warrant Agreement.

   

  Warrants may be exercised at any time during the Exercise Period set
      forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering this Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed, together
      with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as provided for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise of
      Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of
      Warrants not exercised.

   

  Notwithstanding anything else in this Warrant Certificate or the Warrant
      Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering the shares of Common Stock to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating to the
      shares of Common Stock is current, except through “cashless exercise” as provided for in the Warrant Agreement.

   

  The Warrant Agreement provides that upon the occurrence of certain events
      the number of shares of Common Stock issuable upon exercise of the Warrants set forth on the face hereof may, subject to certain conditions, be adjusted.

   

  Warrant Certificates, when surrendered at the principal corporate trust
      office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without
      payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like number of Warrants.

   

  Upon due presentation for registration of transfer of this Warrant
      Certificate at the office of the Warrant Agent, a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate,
      subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection therewith.

   

  

  The Company and the Warrant Agent may deem and treat the Registered
      Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for all
      other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company.

    

  

  
    A-3

    
      
 

  

  
   

  Election to Purchase

   

  (To Be Executed Upon Exercise of Warrant)

   

  The undersigned hereby irrevocably elects to exercise the right,
      represented by this Warrant Certificate, to receive shares of Common Stock and herewith tenders payment for such shares of Common Stock to the order of Heartland Media Acquisition Corp. (the “Company”) in the amount of $                in
      accordance with the terms hereof. The undersigned requests that a certificate for such shares of Common Stock be registered in the name of                , whose address is                and that such shares of Common Stock be delivered
      to             whose address is               . If said number of shares of Common Stock is less than all of the shares of Common Stock purchasable hereunder, the undersigned requests that a new Warrant Certificate representing the remaining balance
      of such shares of Common Stock be registered in the name of                , whose address is                and that such Warrant Certificate be delivered to         , whose address is               .

   

  In the event that the Warrant has been called for redemption by the Company
      pursuant to Section 6.1 of the Warrant Agreement and the Company has required cashless exercise pursuant to Sections 6.4 and 3.3.1(b) of the Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable for
      shall be determined in accordance with subsection 3.3.1(b) of the Warrant Agreement.

   

  In the event that the Warrant has been called for redemption by the
      Company pursuant to Section 6.2 of the Warrant Agreement and a holder thereof elects to exercise its Warrant pursuant to a Make-Whole Exercise, the number of shares of Common Stock that this Warrant is exercisable for shall be determined in
      accordance with Section 6.2 of the Warrant Agreement.

   

  In the event that the Warrant is a Private Placement Warrant or Working
      Capital Warrant that is to be exercised on a “cashless” basis pursuant to subsection 3.3.1(c) of the Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable for shall be determined in accordance with subsection
        3.3.1(c) of the Warrant Agreement.

   

  In the event that the Warrant is to be exercised on a “cashless” basis
      pursuant to Section 7.4 of the Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable for shall be determined in accordance with Section 7.4 of the Warrant Agreement.

   

  In the event that the Warrant may be exercised, to the extent allowed by
      the Warrant Agreement, through cashless exercise (i) the number of shares of Common Stock that this Warrant is exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless
      exercise and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive
      shares of Common Stock. If said number of shares is less than all of the shares of Common Stock purchasable hereunder (after giving effect to the cashless exercise), the undersigned requests that a new Warrant Certificate representing the remaining
      balance of such shares of Common Stock be registered in the name of             , whose address is                 and that such Warrant Certificate be delivered to                , whose address is               .

   

   

    

  [Signature Page Follows]

    

   

  

  
    A-4

    
      
 

  

   

  Date:                , 20

   

  

  	 	 
	 	(Signature)
	 	 
	 	 
	 	 
	 	 
	 	 
	 	(Address)
	 	 
	 	 
	 	 
	 	(Tax Identification Number)

   

  Signature Guaranteed:

   

  THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION
      (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 (OR ANY SUCCESSOR RULE)).

   

  
    A-5

    
      
 

  

  Exhibit B

   

  Legend

   

  “THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN
      EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT BY AND AMONG HEARTLAND MEDIA ACQUISITION CORP. (THE “COMPANY”), HEARTLAND SPONSOR LLC AND THE OTHER PARTIES
      THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT
      AGREEMENT BETWEEN THE COMPANY AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS WARRANT AGENT (THE “WARRANT AGREEMENT”)) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 2 OF THE WARRANT AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY
      TO BE SUBJECT TO SUCH TRANSFER PROVISIONS. SECURITIES EVIDENCED BY THIS CERTIFICATE AND SHARES OF CLASS A COMMON STOCK OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS
      AGREEMENT TO BE EXECUTED BY THE COMPANY.”

   

  No. Warrants

   

  B-1Exhibit 10.2

   

  

  [●], 2022

   

  Heartland
      Media Acquisition Corp. 

  3282
      Northside Pkwy 

  Suite
      275 

  Atlanta,
      GA 30327 

  Attention:
      Robert S. Prather, Jr.

   

  Re:
      Initial Public Offering

   

  Ladies
      and Gentlemen:

   

  This
      letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the
      “Underwriting Agreement”) entered into or proposed to be entered into by and among Heartland Media Acquisition
      Corp., a Delaware corporation (the “Company”), and BofA Securities, Inc. and Moelis & Company LLC (“Moelis”),
      as the representatives (the “Representatives”) of the several underwriters named therein (collectively, the
      “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”)
      of up to 20,125,000 of the Company’s units (including up to 2,625,000 units that may be purchased to cover over-allotments,
      if any) (the “Units”), each comprised of one share of the Company’s Class A common stock, par value $0.0001
      per share (“Common Stock”), and one-half of one redeemable warrant (each, a “Warrant”).
      Each whole Warrant entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to
      adjustment. The Units will be sold in the Public Offering pursuant to a registration statement on Form S-1, as amended, and prospectus,
      as amended (the “Prospectus”) filed by the Company with the Securities and Exchange Commission (the “Commission”)
      and the Company has applied to have the Units listed on the New York Stock Exchange. Certain capitalized terms used herein are
      defined in paragraph 11 hereof.

   

  In
      order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the Public Offering
      and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Heartland Sponsor
      LLC (the “Sponsor”) and each of the undersigned (each, an “Insider” and collectively, the
      “Insiders”), hereby agree, severally but not jointly, with the Company as follows:

   

  1.       The
      Sponsor and each Insider agrees that if the Company seeks stockholder approval of a proposed Business Combination, then in connection
      with such proposed Business Combination, it, he or she shall (i) vote any shares of Capital Stock owned by it, him or her in favor
      of any proposed Business Combination and (ii) not redeem any shares of Capital Stock owned by it, him or her in connection with
      such stockholder approval. If the Company engages in a tender offer in connection with any proposed Business Combination, the
      Sponsor and each Insider agrees that it, he or she will not sell or tender any shares of Capital Stock owned by it, him or her
      to the Company in connection therewith.

   

  
     

    
      

    

  

   

  2.       The
      Sponsor and each Insider hereby agrees that in the event that the Company fails to consummate a Business Combination within 18
      months from the closing of the Public Offering, or up to 21 months from the closing of the Public Offering at (a) the election
      of the Company, to extend such time up to an additional three months, subject to certain conditions, including the deposit of
      $1,750,000 (or $0.10 per Unit) into the Trust Account or (b) the approval by the Company’s stockholders in accordance with
      the Company’s amended and restated certificate of incorporation (any such additional period, an “Extension Period”),
      it, he or she shall take all reasonable steps to cause the Company to (i) cease all operations except for the purpose of winding
      up, (ii) as promptly as reasonably possible but not more than ten (10) Business Days thereafter, redeem 100% of the shares of
      Common Stock sold as part of the Units in the Public Offering (the “Offering Shares”), at a per share price,
      payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held
      in the Trust Account (net of taxes payable and less up to $100,0000 of interest to pay dissolution expenses), divided by the number
      of then outstanding Offering Shares, which redemption will completely extinguish all Public Stockholders’ rights as stockholders
      of the Company (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably
      possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s
      board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide
      for claims of creditors and other requirements of applicable law. The Sponsor and each Insider agrees not to propose any amendment
      to the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s
      obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Offering
      Shares if the Company does not complete a Business Combination within 18 months from the closing of the Public Offering or during
      any Extension Period, or with respect to any other provision relating to stockholders rights or pre-initial Business Combination
      activity, unless the Company provides Public Stockholders with the opportunity to redeem their Offering Shares upon approval of
      any such amendment at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account,
      including interest earned on the funds held in the Trust Account (net of taxes payable), divided by the number of then outstanding
      Offering Shares.

    

   

  The
      Sponsor and each Insider acknowledges that, with respect to the Founder Shares and Private Placement Warrants held by it, he or
      she, it, he or she has no right, title, interest or claim of any kind in or to any monies held in the Trust Account as a result
      of any liquidation of the Company (although the Sponsor and the Insiders shall be entitled to redemption and liquidation rights
      with respect to any Offering Shares it or they hold if the Company fails to consummate a Business Combination within 18 months
      from the date of the closing of the Public Offering or during any Extension Period). The Sponsor and each Insider hereby further
      waives, with respect to any shares of Capital Stock held by it, him or her, if any, any redemption rights it, he or she may have
      in connection with (A) the consummation of a Business Combination, including, without limitation, any such rights available in
      the context of a stockholder vote to approve such Business Combination or in the context of a tender offer made by the Company
      to purchase shares of Common Stock, or (B) a stockholder vote to approve an amendment to the Company’s amended and restated
      certificate of incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection
      with the Company’s initial Business Combination or to redeem 100% of the Offering Shares if the Company has not consummated
      a Business Combination within 18 months from the closing of the Public Offering or during any Extension Period, or (ii) with respect
      to any other provision relating to stockholders rights or pre-initial Business Combination activity.

   

  3.       Notwithstanding
      the provisions set forth in paragraphs 7(a) and (b) below, during the period commencing on the date of the Underwriting Agreement
      and ending 180 days after such date, the Sponsor and each Insider shall not, without the prior written consent of BofA Securities,
      Inc., except with respect to Moelis, (i) offer, pledge, hypothecate, sell, contract to sell, sell any option or contract to purchase,
      purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose
      of or agree to transfer or dispose of, directly or indirectly, any Units, shares of Common Stock, Founder Shares, Warrants or
      any securities convertible into, or exercisable, or exchangeable for, any Units, Common Stock, Founder Shares or Warrants, (ii)
      file with, or submit to, the Commission a registration statement under the Securities Act of 1933, as amended (the “Securities
        Act”) relating to any Units, shares of Common Stock, Founder Shares, Warrants or any securities convertible into, or
      exercisable, or exchangeable for, any Units, Common Stock, Founder Shares or Warrants, (iii) establish or increase a put equivalent
      position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of
      1934, as amended (“Section 16”) with respect to any Units, shares of Common Stock, Founder Shares, Warrants
      or any securities convertible into, or exercisable, or exchangeable for, any Units, Common Stock, Founder Shares or Warrants,
      (iv) enter into any swap or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership
      of any Units, shares of Common Stock, Founder Shares, Warrants or any securities convertible into, or exercisable, or exchangeable
      for, any Units, Common Stock, Founder Shares or Warrants whether any such transaction is to be settled by delivery of such securities,
      in cash or otherwise, or (v) publicly disclose the intention to undertake any transaction specified in clause (i), (ii), (iii)
      or (iv) above; provided, however, the foregoing shall not apply to the forfeiture of any Founder Shares pursuant
      to their terms.

   

  
     

    
      

    

  

   

  Only
      with respect to Moelis, notwithstanding the provisions set forth in this section, Moelis agrees not to sell, transfer, assign,
      pledge, or hypothecate its Class A Common Stock, Warrants or the Class A Common Stock underlying such Warrants (collectively,
      the “Restricted Securities”), nor shall such Restricted Securities be the subject of any hedging, short-sale,
      derivative, put, or call transaction that would result in the effective economic disposition of the securities for a period of
      180 days beginning on the date of commencement of the sales of the Public Offering.

    

   

  4.       In
      the event of the liquidation of the Trust Account upon the failure of the Company to consummate a Business Combination within
      18 months from the date of the closing of the Public Offering or during any Extension Period, the Sponsor (which for purposes
      of clarification shall not extend to the stockholders, members or managers of the Sponsor or any of the other undersigned) agrees
      to indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever (including,
      but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any
      litigation, whether pending or threatened, or any claim whatsoever) to which the Company may become subject as a result of any
      claim by (i) any third party (other than the Company’s independent registered public accounting firm) for services rendered
      or products sold to the Company or (ii) a prospective target business with which the Company has discussed entering into a transaction
      agreement (a “Target”); provided, however, that such indemnification of the Company by the Sponsor
      (x) shall apply only to the extent necessary to ensure that such claims by a third party (other than the Company’s independent
      registered public accounting firm) for services rendered or products sold to the Company or a Target do not reduce the amount
      of funds in the Trust Account to below (i) $10.25 per Offering Share or (ii) such lesser amount per Offering Share held in the
      Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each
      case, net of the amount of interest earned on the property in the Trust Account which may be withdrawn to pay the Company’s
      taxes (less up to $100,000 of interest to pay dissolution expenses), (y) shall not apply to any claims by a third party who executed
      a waiver of any and all rights to seek access to the Trust Account and (z) shall not apply to any claims under the Company’s
      indemnity of the Underwriters against certain liabilities, including liabilities under the Securities Act. In the event that any
      such executed waiver is deemed to be unenforceable against such third party, the Sponsor shall not be responsible to the extent
      of any liability for such third party claims. The Sponsor shall have the right to defend against any such claim with counsel of
      its choice reasonably satisfactory to the Company if, within 15 days following written receipt of notice of the claim to the Sponsor,
      the Sponsor notifies the Company in writing that it shall undertake such defense.

   

  
     

    
      

    

  

   

  5.       To
      the extent that the Underwriters do not exercise their over-allotment option to purchase up to an additional 2,625,000 Units within
      45 days from the date of the Prospectus (and as further described in the Prospectus), the Sponsor agrees that it shall forfeit,
      at no cost, a number of Founder Shares equal to the product of 656,250 multiplied by a fraction, (i) the numerator of which is
      2,625,000 minus the number of Units purchased by the Underwriters upon the exercise of their over-allotment option, and (ii) the
      denominator of which is 2,625,000. The forfeiture will be adjusted to the extent that the over-allotment option is not exercised
      in full by the Underwriters so that the number of Founder Shares will represent an aggregate of 20.0% of the Company’s issued
      and outstanding shares of Capital Stock after the Public Offering (not including shares of Common Stock underlying the Warrants
      or the Private Placement Warrants). The Initial Stockholders agree that to the extent that the size of the Public Offering is
      increased or decreased, the Company will effect a stock dividend or share repurchase or contribution back to capital, as applicable,
      immediately prior to the consummation of the Public Offering in such amount as to maintain the number of Founder Shares at 20.0%
      of its issued and outstanding shares of Capital Stock upon the consummation of the Public Offering (not including shares of Common
      Stock underlying the Warrants or the Private Placement Warrants). In connection with such increase or decrease in the size of
      the Public Offering, then (A) the references to 2,625,000 in the numerator and denominator of the formula in the first sentence
      of this paragraph shall be changed to a number equal to 15.0% of the number of shares included in the Units issued in the Public
      Offering and (B) the reference to 656,250 in the formula set forth in the first sentence of this paragraph 5 shall be adjusted
      to such number of Founder Shares that the Sponsor would have to return to the Company in order for the number of Founder Shares
      to equal an aggregate of 20.0% of the Company’s issued and outstanding shares of Capital Stock after the Public Offering
      (not including shares of Common Stock underlying the Warrants or the Private Placement Warrants).

    

   

  6.       The
      Sponsor and each Insider hereby agrees and acknowledges that: (i) the Underwriters and the Company would be irreparably injured
      in the event of a breach by such Sponsor or Insider of its, his or her obligations under paragraphs 1, 2, 3, 4, 5, 7(a), 7(b),
      8 and 9 of this Letter Agreement, (ii) monetary damages may not be an adequate remedy for such breach and (iii) the non-breaching
      party shall be entitled to seek injunctive relief, in addition to any other remedy that such party may have in law or in equity,
      in the event of such breach.

    

   

  7.       (a)
      The Sponsor and each Insider agrees that it, he or she shall not Transfer any Founder Shares (or shares of Common Stock issuable
      upon conversion thereof) until the earlier of (A) one year after the completion of the Company’s initial Business Combination
      and (B) subsequent to the Company’s initial Business Combination, if the last reported sale price of the Common Stock equals
      or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for
      any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination,
      or the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction
      that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities
      or other property (the “Founder Shares Lock-up Period”).

   

  (b)
      The Sponsor and each Insider agrees that, to the extent it, he or she holds Private Placement Warrants, it, he or she shall not
      Transfer any Private Placement Warrants (or shares of Common Stock issued or issuable upon the exercise of the Private Placement
      Warrants), until 30 days after the completion of the Company’s initial Business Combination (the “Private Placement
        Warrants Lock-up Period,” together with the Founder Shares Lock-up Period, the “Lock-up Periods”).

    

   

  (c)
      Notwithstanding the provisions set forth in paragraphs 7(a) and (b), Transfers of the Founder Shares, Private Placement Warrants
      and shares of Common Stock issued or issuable upon the exercise or conversion of the Private Placement Warrants or the Founder
      Shares and that are held by the Sponsor, any Insider or any of their permitted transferees (that have complied with this paragraph
      7(c)), are permitted (a) to the Company’s officers or directors, any affiliates or family members of any of the Company’s
      officers or directors, any members of the Sponsor or any affiliates of the Sponsor; (b) in the case of an individual, by gift
      to a member of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s
      immediate family or an affiliate of such person, or to a charitable organization; (c) in the case of an individual, by virtue
      of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic
      relations order; (e) by private sales or transfers made in connection with the consummation of a Business Combination at prices
      no greater than the price at which the Founder Shares, Private Placement Warrants and shares of Common Stock were originally purchased;
      (f) in the event of the Company’s liquidation prior to the completion of its initial Business Combination; (g) by virtue
      of the laws of the State of Delaware or the Sponsor’s limited liability company agreement, as amended, upon dissolution
      of the Sponsor; or (h) in the event of the Company’s completion of a liquidation, merger, stock exchange, reorganization
      or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares
      of common stock for cash, securities or other property subsequent to the Company’s completion of a Business Combination;
      provided, however, that in the case of clauses (a) through (g), these permitted transferees must enter into a written agreement
      with the Company agreeing to be bound by the transfer restrictions herein and the other restrictions contained in this Agreement
      (including provisions relating to voting, the Trust Account and liquidating distributions).

    

   

  
     

    
      

    

  

   

  8.       The
      Sponsor and each Insider represents and warrants that it, he or she has never been suspended or expelled from membership in any
      securities or commodities exchange or association or had a securities or commodities license or registration denied, suspended
      or revoked. Each Insider’s biographical information furnished to the Company (including any such information included in
      the Prospectus) is true and accurate in all respects and does not omit any material information with respect to the undersigned’s
      background. Each Insider’s questionnaire furnished to the Company and the Representatives is true and accurate in all respects.
      Each Insider represents and warrants that: such Insider is not subject to or a respondent in any legal action for, any injunction,
      cease-and-desist order or order or stipulation to desist or refrain from any act or practice relating to the offering of securities
      in any jurisdiction; such Insider has never been convicted of, or pleaded guilty to, any crime (i) involving fraud, (ii) relating
      to any financial transaction or handling of funds of another person or (iii) pertaining to any dealings in any securities and
      it is not currently a defendant in any such criminal proceeding.

   

  9.       Except
      as disclosed in, or expressly contemplated by, the Prospectus, none of the Sponsor, any officer or director of the Company or
      any affiliate of the Sponsor or any director or officer of the Company, shall receive from the Company any finder’s fee,
      reimbursement, consulting fee, monies in respect of any repayment of a loan or other compensation prior to, or in connection with
      any services rendered in order to effectuate the consummation of the Company’s initial Business Combination (regardless
      of the type of transaction that it is).

    

   

  10.       The
      Sponsor and each Insider has full right and power, without violating any agreement to which it is bound (including, without limitation,
      any non-competition or non-solicitation agreement with any employer or former employer), to enter into this Letter Agreement and,
      as applicable, to serve as an officer and/or a director of the Company, as applicable, and hereby consents to being named in the
      Prospectus as an officer and/or director of the Company, as applicable.

    

   

  11.       As
      used herein, (i) “Business Combination” shall mean any merger, capital stock exchange, asset acquisition, stock purchase,
      reorganization or similar business combination, involving the Company and one or more businesses; (ii) “Business Day”
      means each day that is not a Saturday, Sunday or other day on which banking institutions in The City of New York, New York, are
      authorized or required by law to close; (iii) “Capital Stock” shall mean, collectively, the Common Stock and the Founder
      Shares; (iv) “Founder Shares” shall mean the 5,031,250 shares of the Company’s Class B common stock, par value
      $0.0001 per share, issued and outstanding as of the date hereof (up to 656,250 of which are subject to forfeiture by the Sponsor
      depending on the extent to which the Underwriters’ over-allotment option is exercised); (v) “Initial Stockholders”
      shall mean the Sponsor and any Insider that holds Founder Shares prior to the consummation of the Public Offering; (vi) “Private
      Placement Warrants” shall mean the 9,875,000 warrants (11,056,250 warrants if the Underwriters’ over-allotment option
      is exercised in full) to purchase shares of Common Stock of the Company that the Sponsor has agreed to purchase for an aggregate
      purchase price of $9,875,000 (or $11,056,250 if the Underwriters’ over-allotment option is exercised in full) in a private
      placement that shall occur simultaneously with the consummation of the Public Offering; (vii) “Public Stockholders”
      shall mean the holders of the Offering Shares; (viii) “Trust Account” shall mean the trust fund into which a portion
      of the net proceeds of the Public Offering and the sale of the Private Placement Warrants shall be deposited; and (ix) “Transfer”
      shall mean the (a) sale or assignment of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option
      to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put
      equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16
      and the rules and regulations of the Commission promulgated thereunder with respect to, any security, (b) entry into any swap
      or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security,
      whether any such transaction is to be settled by delivery of such securities, in cash or otherwise or (c) public announcement
      of any intention to effect any transaction specified in clause (a) or (b).

   

  
     

    
      

    

  

   

  12.       The
      Company will maintain an insurance policy or policies providing directors’ and officers’ liability insurance, and
      each officer or director of the Company shall be covered by such policy or policies, in accordance with its or their terms, to
      the maximum extent of the coverage available for any of the Company’s officers or directors.

    

   

  13.       This
      Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof
      and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the
      extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may
      not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except
      by a written instrument executed by (1) each Insider that is the subject of any such change, amendment, modification or waiver,
      (2) the Company and (3) the Sponsor.

    

   

  14.       No
      party hereto may assign either this Letter Agreement or any of its rights, interests or obligations hereunder without the prior
      written consent of the other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and
      shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding
      on the Company, the Sponsor and each Insider and their respective successors, heirs and assigns and permitted transferees.

    

   

  15.       This
      Letter Agreement may be executed in any number of original, facsimile or other electronic counterparts and each of such counterparts
      shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

    

   

  16.       This
      Letter Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect
      the validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any
      such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Letter
      Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

    

   

  17.       This
      Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York (including,
      without limitation, Sections 5-1401 and 5-1402 of the New York General Obligations Law and New York Civil Practice Laws and Rules
      327(b)), without giving effect to conflicts of law principles that would result in the application of the substantive laws of
      another jurisdiction. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating
      in any way to, this Letter Agreement shall be brought and enforced in the courts of New York City, in the State of New York, and
      irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection
      to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.

    

   

  18.       Any
      notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in
      writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by
      hand delivery or facsimile transmission.

   

  19.       This
      Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-up Periods and (ii) the liquidation of the Company;
      provided, however, that this Letter Agreement shall earlier terminate in the event that the Public Offering is not
      consummated by June 30, 2022; provided further that paragraph 4 of this Letter Agreement shall survive such liquidation.

      

    

   

  [Signature
      Page Follows]

   

  
     

    
      

    

  

   

  	 	Sincerely,
	 	 	 
	 	HEARTLAND SPONSOR LLC
	 	 	 
	 	By:	 
	 	 	Name: Robert S. Prather, Jr.
	 	 	Title: Managing Member
	 	 	 
	 	 	 
	 	 	Robert S. Prather, Jr.
	 	 	 
	 	 	 
	 	 	Salvatore Muoio
	 	 	 
	 	 	 
	 	 	Steven Shapiro
	 	 	 
	 	 	 
	 	 	Alan Weber
	 	 	 
	 	 	 
	 	 	John Zieser
	 	 	 
	 	 
	 	Moelis & Company LLC
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

  

  

   

   

  

  [Signature
        Page to Letter Agreement]

   

  
     

    
      

    

  

   

  	 	Acknowledged and Agreed:
	 	
          HEARTLAND
                MEDIA ACQUISITION CORP.

        
	 	 
	 	By:	 
	 	 	Name:	 Robert S. Prather, Jr.
	 	 	Title:    	 Chief Executive Officer

   

   

  

  [Signature
        Page to Letter Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]